RECURRENT HEAD AND NECK CANCER
Clinical trials for RECURRENT HEAD AND NECK CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HEAD AND NECK CANCER trials appear
Sign up with your email to follow new studies for RECURRENT HEAD AND NECK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Sound waves boost cancer drug in tiny trial
Disease control Recruiting nowThis early-stage trial tests whether using ultrasound and microbubbles can help the immunotherapy drug pembrolizumab work better in people with advanced head and neck cancer. Six participants will receive the drug followed by ultrasound aimed at their tumor. The main goal is to s…
Matched conditions: RECURRENT HEAD AND NECK CANCER
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 17, 2026 07:03 UTC
-
Triple therapy aims to shrink advanced head and neck tumors
Disease control Recruiting nowThis study tests a combination of three treatments—modified immune cells (PD-L1 t-haNK), an immune-boosting protein (NAI/Anktiva), and a targeted antibody (cetuximab)—in 25 adults with advanced head and neck cancer that has returned or spread. The goal is to see if this mix can s…
Matched conditions: RECURRENT HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: Glenn J. Hanna • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
New combo therapy targets HPV-driven head and neck cancer in major trial
Disease control Recruiting nowThis study tests whether adding an experimental vaccine (BNT113) to a standard immunotherapy (pembrolizumab) works better than the immunotherapy alone for people with advanced head and neck cancer caused by HPV. About 350 adults with incurable, recurrent, or metastatic cancer wil…
Matched conditions: RECURRENT HEAD AND NECK CANCER
Phase: PHASE2, PHASE3 • Sponsor: BioNTech SE • Aim: Disease control
Last updated May 15, 2026 11:53 UTC